Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tums is a leading brand of antacid products used to provide fast-acting relief from heartburn, acid indigestion, and sour stomach. Originally created in 1928 by pharmacist James Howe, the brand is now owned by Haleon, a global leader in consumer health. The primary active ingredient in Tums products is calcium carbonate, which works by neutralizing excess gastric acid in the esophagus and stomach. The product line includes various formulations such as chewable tablets, sugar-free options, and extra-strength varieties. Tums is one of the most recognized over-the-counter digestive health brands in North America and is manufactured at a dedicated facility in St. Louis, Missouri.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tums.